| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
Homo sapiens
|
Aug 08, 2021
|
|||||||
| GSM3324737 |
HCC827 DMSO rep1
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324738 |
HCC827 DMSO rep2
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324739 |
HCC827 GSK-J4 rep1
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324740 |
HCC827 GSK-J4 rep2
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324741 |
H23 DMSO rep1
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324742 |
H23 DMSO rep2
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324743 |
H23 GSK-J4 rep1
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324744 |
H23 GSK-J4 rep2
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324745 |
A549 DMSO rep1
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324746 |
A549 DMSO rep2
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324747 |
A549 GSK-J4 rep1
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3324748 |
A549 GSK-J4 rep2
|
SRA |
|
1 | Mi Young Kim | Aug 08, 2021 | |||
| GSM3325727 |
PBS treatment, PAEC line 1
|
RNA |
|
1 | Wei Li | Aug 08, 2021 | |||
| GSM3325728 |
PBS treatment, PAEC line 2
|
RNA |
|
1 | Wei Li | Aug 08, 2021 | |||
| GSM3325729 |
PBS treatment, PAEC line 3
|
RNA |
|
1 | Wei Li | Aug 08, 2021 | |||
| GSM3325730 |
PBS treatment, PAEC line 4
|
RNA |
|
1 | Wei Li | Aug 08, 2021 | |||
| GSM3325731 |
pro-BMP9 treatment, PAEC line 1
|
RNA |
|
1 | Wei Li | Aug 08, 2021 | |||
| GSM3325732 |
pro-BMP9 treatment, PAEC line 2
|
RNA |
|
1 | Wei Li | Aug 08, 2021 | |||
| GSM3325733 |
pro-BMP9 treatment, PAEC line 3
|
RNA |
|
1 | Wei Li | Aug 08, 2021 | |||
| GSM3325734 |
pro-BMP9 treatment, PAEC line 4
|
RNA |
|
1 | Wei Li | Aug 08, 2021 |
